Loading...
By Amy Orciari Herman
Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM
Rates of sudden death in patients with heart failure declined significantly over the past two decades, finds a study in the New England Journal of Medicine.
Researchers examined data on some 40,000 adults with symptomatic heart failure and reduced ejection fraction who participated in any of 12 randomized trials between 1995 and 2014. Patients with implantable cardioverter-defibrillators were excluded.
Overall, sudden death occurred in 9% of participants. The annual rate of sudden death declined from 6.5% in the earliest trial to 3.3% in the most recent. The decline was seen across ejection fraction subgroups.
The authors say their findings are "consistent with a cumulative benefit of evidence-based medications on sudden death." Meanwhile, Dr. Harlan Krumholz, editor-in-chief of NEJM Journal Watch Cardiology, notes that "it's difficult to make inferences about trends in outcomes by combining randomized trials conducted in different periods."
Comment
LINK(S):
NEJM article (Free abstract)
Background: Recent Physician's First Watch coverage of heart failure guideline update (Free)